NYSE:MSTX

Mast Therapeutics Stock Insider Trading

etoro logo Buy MSTX
*Your capital is at risk
$15.54
-2.56 (-14.14%)
At Close: Jun 05, 2026

Mast Therapeutics Stock Insider Power

Based on the 45 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 9.3M and sold 0 MSTX shares in the last 45 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 45 transactions)
0
Buy 9.3M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jan 23, 2017
Buy
Restricted Stock Units
A-Award
Pauls Matthew
Director
Director 45 535
Value: $0
Jan 20, 2017
Buy
Restricted Stock Units
A-Award
Greenleaf Peter
Director
Director 45 535
Value: $0
Jan 20, 2017
Buy
Restricted Stock Units
A-Award
Ramsay David A
Director
Director 79 962
Value: $0
Jan 20, 2017
Buy
Restricted Stock Units
A-Award
Hood Shana
General Counsel & Vp
Officer 453 556
Value: $0
Jan 20, 2017
Buy
Restricted Stock Units
A-Award
Roberts Brandi
Chief Financial Officer & SVP
C-Suite Officer 889 926
Value: $0
Jun 15, 2016
Buy
Stock Option (Right to Buy)
A-Award
Ramsay David A
Director
Director 79 551
Value: $34.2K
Jun 15, 2016
Buy
Stock Option (Right to Buy)
A-Award
Pauls Matthew
Director
Director 79 551
Value: $34.2K
Jun 15, 2016
Buy
Stock Option (Right to Buy)
A-Award
Greenleaf Peter
Director
Director 79 551
Value: $34.2K
Jan 19, 2016
Buy
Employee Stock Option (Right to Buy)
Hood Shana
General Counsel & Vp
Officer 93 650
Value: $60.9K
Jan 19, 2016
Buy
Employee Stock Option (Right to Buy)
Hood Shana
General Counsel & Vp
Officer 37 450
Value: $22.5K
Jan 19, 2016
Buy
Employee Stock Option (Right to Buy)
Hood Shana
General Counsel & Vp
Officer 27 069
Value: $62.0K
Jan 19, 2016
Buy
Employee Stock Option (Right to Buy)
Hood Shana
General Counsel & Vp
Officer 11 250
Value: $66.5K
Jan 19, 2016
Buy
Employee Stock Option (Right to Buy)
Hood Shana
General Counsel & Vp
Officer 409 000
Value: $171.8K
Jan 19, 2016
Buy
Employee Stock Option (Right to Buy)
Hood Shana
General Counsel & Vp
Officer 95 500
Value: $47.8K
Jan 19, 2016
Buy
Employee Stock Option (Right to Buy)
Hood Shana
General Counsel & Vp
Officer 25 600
Value: $12.0K
Jan 19, 2016
Buy
Employee Stock Option (Right to Buy)
Hood Shana
General Counsel & Vp
Officer 176 500
Value: $102.4K
Jan 19, 2016
Buy
Employee Stock Option (Right to Buy)
Hood Shana
General Counsel & Vp
Officer 22 400
Value: $13.2K
Jan 04, 2016
Buy
Employee Stock Option (Right to Buy)
A-Award
Emanuele Robert Martin
Senior Vp, Development
Officer 572 700
Value: $240.5K
Jan 04, 2016
Buy
Employee Stock Option (Right to Buy)
A-Award
Roberts Brandi
Chief Financial Officer & SVP
C-Suite Officer 572 700
Value: $240.5K
Nov 05, 2015
Buy
Stock Option (Right to Buy)
A-Award
Greenleaf Peter
Director
Director 64 791
Value: $29.2K
Nov 05, 2015
Buy
Stock Option (Right to Buy)
A-Award
Greenleaf Peter
Director
Director 37 794
Value: $17.0K
Nov 05, 2015
Buy
Common Stock
J-Other
Greenleaf Peter
Director 0
Value: $0
Oct 29, 2015
Buy
Stock Option (Right to Buy)
A-Award
Pauls Matthew
Director
Director 64 791
Value: $31.1K
Oct 29, 2015
Buy
Stock Option (Right to Buy)
A-Award
Pauls Matthew
Director
Director 37 794
Value: $18.1K
Oct 29, 2015
Buy
Common Stock
J-Other
Pauls Matthew
Director 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MAST THERAPEUTICS, INC
Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE